Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Protagonist Therapeutics
PTGX
$10B
| $942K | ﹤0.01% |
32,567
-181,400
| -85% | -$4.94M |
|
2527
GrafTech
EAF
$199M
| $933K | ﹤0.01% |
67,610
-53,800
| -44% | -$839K |
|
2528
iShares Core US REIT ETF
USRT
$4.64B
| $931K | ﹤0.01% |
17,300
+7,700
| +80% | +$408K |
|
2529
Marten Transport
MRTN
$1.24B
| $929K | ﹤0.01% |
50,266
+20,766
| +70% | +$399K |
|
2530
Brighthouse Financial
BHF
$3.37B
| $928K | ﹤0.01% |
+18,000
| New | +$894K |
|
2531
Vanguard Industrials ETF
VIS
$8.54B
| $928K | ﹤0.01% |
3,800
-300
| -7% | -$68.1K |
|
2532
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $925K | ﹤0.01% |
17,600
-9,800
| -36% | -$484K |
|
2533
Invesco Aerospace & Defense ETF
PPA
$8.77B
| $924K | ﹤0.01% |
9,100
-15,300
| -63% | -$1.45M |
|
2534
MaxLinear
MXL
$7.69B
| $922K | ﹤0.01% |
49,391
-204,013
| -81% | -$4.07M |
|
2535
Sight Sciences
SGHT
$448M
| $922K | ﹤0.01% |
174,656
+97,256
| +126% | +$457K |
|
2536
Myomo
MYO
$68.1M
| $921K | ﹤0.01% |
281,700
+88,100
| +46% | +$319K |
|
2537
Schwab U.S Small- Cap ETF
SCHA
$23.7B
| $921K | ﹤0.01% |
+37,400
| New | +$876K |
|
2538
First US Bancshares
FUSB
$90.6M
| $919K | ﹤0.01% |
99,221
-2,800
| -3% | -$27.7K |
|
|
SCTL
2539
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $918K | ﹤0.01% |
850,317
+19,100
| +2% | +$12.3K |
|
2540
Solid Biosciences
SLDB
$986M
| $916K | ﹤0.01% |
68,771
+30,700
| +81% | +$287K |
|
2541
Sibanye-Stillwater
SBSW
$7.62B
| $915K | ﹤0.01% |
+194,200
| New | +$892K |
|
2542
Cumberland Pharmaceuticals
CPIX
$117M
| $912K | ﹤0.01% |
542,663
-7,200
| -1% | -$14.4K |
|
2543
Moog Inc Class B
MOG.B
| $911K | ﹤0.01% |
5,800
-100
| -2% | -$14.4K |
|
2544
US Physical Therapy
USPH
$1.21B
| $908K | ﹤0.01% |
8,049
-7,600
| -49% | -$759K |
|
2545
Rallybio
RLYB
$90.2M
| $903K | ﹤0.01% |
+61,013
| New | +$850K |
|
2546
Zevra Therapeutics
ZVRA
$672M
| $901K | ﹤0.01% |
155,400
-15,100
| -9% | -$92.8K |
|
2547
Fidelity Wise Origin Bitcoin Fund
FBTC
$11.7B
| $900K | ﹤0.01% |
+14,500
| New | +$694K |
|
2548
Avantis International Equity ETF
AVDE
$18.8B
| $899K | ﹤0.01% |
+14,100
| New | +$858K |
|
|
WKME
2549
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $899K | ﹤0.01% |
104,500
+41,700
| +66% | +$406K |
|
2550
Mistras Group
MG
$576M
| $897K | ﹤0.01% |
93,800
+9,500
| +11% | +$79.2K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.